3 citations
,
September 2021 in “EClinicalMedicine” In this study, ALRV5XR treatment significantly increased terminal hair density in men with androgenetic alopecia after 24 weeks, while also decreasing vellus hair density, and was well tolerated without adverse events, suggesting its potential efficacy over standard therapies.
October 2020 in “Journal of Pakistan Association of Dermatology” This study found that platelet-rich plasma therapy was more effective in increasing hair count than topical 5% minoxidil lotion in men with androgenetic alopecia.
14 citations
,
September 2020 in “Dermatologic Therapy” This study reported that oral minoxidil improved hair density and had an acceptable safety profile in women with androgenetic alopecia.
October 2019 in “Journal of Pakistan Association of Dermatologists” This study evaluated azathioprine in treating alopecia areata and found that it was effective for 77.4% of patients, significantly reducing SALT scores after 6 months of treatment, with safety monitored through regular testing.
In this study, a combination of GFM-lotion with autologous PRP treatment improved efficacy in treating androgenic alopecia compared to PRP alone, as shown by significant improvements in clinical assessments over 3 months.
80 citations
,
December 2017 in “International Journal of Dermatology” This study reported that once-daily treatment with oral minoxidil and spironolactone for 12 months reduced hair loss severity and hair shedding in women with pattern hair loss, with generally mild side effects, though results came from an uncontrolled, observational pilot study.
In this study, autologous platelet-rich plasma treatment improved androgenic alopecia outcomes in men and women and significantly reduced the area and volume of chronic ulcers.
27 citations
,
January 2017 in “Indian Dermatology Online Journal” This study found no significant benefit from PRP injections for treating androgenetic alopecia in men, highlighting the need for larger, well-designed trials to assess its effectiveness and safety.
This study found that platelet-rich plasma treatments improved hair density and regrowth in men and women with androgenetic alopecia, with better results when combined with minoxidil compared to finasteride.
5 citations
,
November 2016 in “Experimental and Therapeutic Medicine” In this study, BeauTop treatment significantly increased hair growth in people with androgenetic alopecia compared to placebo, showing effectiveness without adverse reactions.
61 citations
,
September 2016 in “Journal of Cosmetic and Laser Therapy” This study found that platelet-rich plasma was not effective in treating androgenetic alopecia in men with grade 4–6 hair loss.
This study found that while hydroxychloroquine was effective and safe for treating alopecia areata, patients using it experienced more relapses compared to those receiving betamethasone.
This study found that low-dose oral finasteride effectively maintained hair in Chinese men with androgenetic alopecia, as shown by significantly lower hair loss rates compared to placebo after 24 and 48 weeks.
12 citations
,
January 2003 in “Dermatology Online Journal” This study reported that a novel cell culture medium gel significantly increased hair counts and reduced hair loss in men with androgenetic alopecia over a six-month period.
